The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

(MENAFN- GlobeNewsWire - Nasdaq) The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a ...

Phil Brooks, a Black American, patented a disposable syringe design on April 9, 1974, contributing to safer healthcare. While not the inventor of the hypodermic syringe, his work added to the history ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

The SPACE trial showed fremanezumab significantly reduced monthly migraine days in pediatric patients compared with placebo. The Food and Drug Administration (FDA) has accepted for review the ...

Subscribe for unlimited access. A subscription to European Rubber Journal includes: Every issue of European Rubber Journal (6 issues) including Special Reports & Maps. Unlimited access to ERJ articles ...

Nucala is available in three forms, all of which are given as an injection under the skin: liquid solution inside a prefilled syringe liquid solution inside a prefilled auto-injector powder inside ...

Read also: Aurobindo Pharma arm gets marketing authorisation for Zefylti in EU Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the ...

Halozyme Therapeutics (HALO) announced that Janssen-Cilag International NV, a Johnson & Johnson (JNJ) company, has received European Commission marketing authorization of the subcutaneous ...